<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Geriatr</journal-id><journal-id journal-id-type="iso-abbrev">BMC Geriatr</journal-id><journal-title-group><journal-title>BMC Geriatrics</journal-title></journal-title-group><issn pub-type="epub">1471-2318</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11681680</article-id><article-id pub-id-type="publisher-id">5637</article-id><article-id pub-id-type="doi">10.1186/s12877-024-05637-3</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Evaluating SARC-F, SARC-CalF, and calf circumference as diagnostic tools for sarcopenia in Thai older adults: results from a nationwide study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Vanitcharoenkul</surname><given-names>Ekasame</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Unnanuntana</surname><given-names>Aasis</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Chotiyarnwong</surname><given-names>Pojchong</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Adulkasem</surname><given-names>Nath</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Asavamongkolkul</surname><given-names>Apichat</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Laohaprasitiporn</surname><given-names>Panai</given-names></name><address><email>panai.lao@mahidol.edu</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01znkr924</institution-id><institution-id institution-id-type="GRID">grid.10223.32</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0490</institution-id><institution>Department of Orthopaedic Surgery, Faculty of Medicine Siriraj Hospital, </institution><institution>Mahidol University, </institution></institution-wrap>2 Wanglang Road, Bangkok Noi, Bangkok, 10700 Thailand </aff></contrib-group><pub-date pub-type="epub"><day>28</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>28</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>24</volume><elocation-id>1043</elocation-id><history><date date-type="received"><day>25</day><month>9</month><year>2024</year></date><date date-type="accepted"><day>16</day><month>12</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">With the increasing number of older adults, musculoskeletal disorders such as sarcopenia have become increasingly important to research because of their strong association with falls and fractures. Sarcopenia, which is characterized by reduced muscle mass, is common among older adults and significantly increases the risk of falls. This study aimed to assess the effectiveness of the SARC-F and SARC-CalF questionnaires, along with calf circumference measurements, for sarcopenia screening among Thai community-dwelling older adults, following the 2019 criteria of the Asian Working Group for Sarcopenia.</p></sec><sec><title>Methods</title><p id="Par2">This analysis drew on data from the Thai Musculoskeletal Diseases Nationwide Study, which included 2543 participants aged 60 years or older. The SARC-F, SARC-CalF, and calf circumference data were evaluated against the 2019 Asian Working Group for Sarcopenia criteria. We calculated the sensitivity, specificity, and area under the curve to determine the diagnostic performance of each tool.</p></sec><sec><title>Results</title><p id="Par3">Of the 2455 participants analyzed, 18.1% were diagnosed with sarcopenia. The SARC-F and SARC-CalF questionnaires showed limited effectiveness in diagnosing sarcopenia, with area under the curve values of 0.508 and 0.729, respectively. In contrast, calf circumference demonstrated greater diagnostic accuracy, with area under the curve values of 0.897 in males and 0.878 in females. Adjusting the cutoff points to &#x0003c;&#x02009;33&#x000a0;cm for males and &#x0003c;&#x02009;31&#x000a0;cm for females improved the overall diagnostic accuracy from 66.4 to 82%.</p></sec><sec><title>Conclusions</title><p id="Par4">Sarcopenia is relatively prevalent in Thailand. The SARC-F and SARC-CalF questionnaires are inadequate for diagnosing sarcopenia, while calf circumference alone is the most effective screening tool. Adding more parameters to the SARC-F questionnaire could enhance its diagnostic accuracy.</p></sec><sec><title>Trial registration</title><p id="Par5">This study was registered at ClinicalTrials.gov (NCT06558617). Registration Date 16 August 2024.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Calf circumference</kwd><kwd>Diagnostic test</kwd><kwd>Elderly</kwd><kwd>SARC-F questionnaire</kwd><kwd>Sarcopenia</kwd></kwd-group><funding-group><award-group><funding-source><institution>Mahidol University</institution></funding-source></award-group><open-access><p>Open access funding provided by Mahidol University</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; BioMed Central Ltd., part of Springer Nature 2024</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par6">The growing number of older adults has made diseases affecting the skeletal, joint, and muscular systems increasingly relevant to research. Over the past decade, osteoporosis has gained significant attention because of advancements in antiosteoporotic medications, resulting in a notable decline in fracture rates [<xref ref-type="bibr" rid="CR1">1</xref>]. However, some patients continue to experience fractures despite appropriate treatment, with falls being a primary contributing factor. Studies indicate that muscle strength plays a crucial role in fall prevention [<xref ref-type="bibr" rid="CR2">2</xref>]. Sarcopenia, a condition characterized by decreased muscle mass in older adults, contributes significantly to reduced muscle strength and an increased risk of falls [<xref ref-type="bibr" rid="CR3">3</xref>].</p><p id="Par7">In 2019, the Asian Working Group for Sarcopenia (AWGS) introduced revised diagnostic criteria and updated cutoff values for sarcopenia. These guidelines recommend the SARC-F questionnaire, SARC-CalF questionnaire, and calf circumference as screening tools for detecting sarcopenia in both primary care and clinical research settings [<xref ref-type="bibr" rid="CR4">4</xref>]. The SARC-F questionnaire has been translated and validated in various languages and clinical contexts [<xref ref-type="bibr" rid="CR5">5</xref>&#x02013;<xref ref-type="bibr" rid="CR9">9</xref>]. Among community-dwelling older adults, the SARC-F and SARC-CalF questionnaires have shown high versatility in identifying sarcopenia cases [<xref ref-type="bibr" rid="CR10">10</xref>]. The sensitivity of the SARC-F questionnaire ranges from 29.5 to 62.8%, whereas that of the SARC-CalF questionnaire ranges from 56.1 to 83% [<xref ref-type="bibr" rid="CR11">11</xref>&#x02013;<xref ref-type="bibr" rid="CR14">14</xref>]. Calf circumference measurement is a quick, simple method for assessing muscle mass, with multiple studies reporting correlations between calf circumference and both lean mass and physical function [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. The reported sensitivities and specificities for calf circumference range from 71 to 83.3% and 62.8&#x02013;84%, respectively [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Thus, factors such as sarcopenia prevalence, ethnicity, study population characteristics, and diagnostic criteria may affect the performance of these screening tools.</p><p id="Par8">To our knowledge, no studies have evaluated the performance of these questionnaires and calf circumference measurements for detecting sarcopenia among Thai community-dwelling older adults. This study aimed to assess the effectiveness of these tools in screening for sarcopenia according to the 2019 AWGS criteria through a nationwide cross-sectional analysis in Thailand.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Study design and population</title><p id="Par9">The data for this analysis were derived from the Thai Musculoskeletal Diseases Nationwide Study, a cross-sectional study conducted from March 2021 to August 2022. The study targeted Thai adults aged 60 years and older via a multilevel sampling technique to ensure the representativeness of community-dwelling older adults across 12 provinces, covering Thailand&#x02019;s six primary geographical regions. The exclusion criteria were individuals with missing data on the SARC-F, SARC-CalF, and calf circumference; those unable to walk independently; bedridden individuals; and those with neuromuscular disorders or severe comorbidities affecting their ability to perform performance-based tests. Six trained research assistants conducted the physical function tests during the study. To ensure consistent instructions, all tests were standardized prior to the study&#x02019;s commencement.</p><p id="Par10">The study protocol was approved by the Siriraj Institutional Review Board of the Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand (COA-715/2024), and the research was registered with ClinicalTrials.gov (NCT06558617). Trained research assistants obtained written informed consent from all participants before their enrollment.</p></sec><sec id="Sec4"><title>Diagnosis of possible Sarcopenia, Dynapenia, and Sarcopenia</title><p id="Par11">To diagnose possible sarcopenia, dynapenia, and sarcopenia, we assessed muscle strength, physical performance, and appendicular skeletal muscle mass (ASM) per the AWGS 2019 criteria. Possible sarcopenia was defined as a decline in muscle strength and/or physical performance. Dynapenia was defined by low muscle function without a decrease in muscle mass [<xref ref-type="bibr" rid="CR18">18</xref>]. Sarcopenia was characterized by low ASM combined with reduced muscle strength and/or physical performance.</p></sec><sec id="Sec5"><title>Muscle strength assessment</title><p id="Par12">Muscle strength was evaluated using handgrip strength measurements. The participants exerted maximum force via a digital Smedley spring hand dynamometer (Takei 5401 Digital Dynamometer; Takei, Tokyo, Japan) while standing with their arms fully extended at their sides. The dynamometer grip size was adjusted for each participant&#x02019;s hand size, and two to three trials were performed. The highest value recorded was used for analysis. Handgrip strength values of &#x0003c;&#x02009;28&#x000a0;kg in males and &#x0003c;&#x02009;18&#x000a0;kg in females were considered indicative of low muscle strength, as per the AWGS 2019 criteria.</p></sec><sec id="Sec6"><title>Physical performance evaluation</title><p id="Par13">Physical performance was assessed through gait speed and the five-time sit-to-stand (5TSTS) test. Gait speed was measured over 5&#x000a0;m via a stopwatch, with participants walking at their usual pace along an 11-meter path. The average time to cover the 3- to 8-meter section was calculated. A gait speed of &#x0003c;&#x02009;1.0&#x000a0;m/s indicated poor performance, per the AWGS 2019 guidelines. The 5TSTS test measures the time required to transition from a sitting position to a standing position and back to sitting; this test is repeated five times. We used a standardized armless chair with a seat height of 43&#x000a0;cm from the floor [<xref ref-type="bibr" rid="CR19">19</xref>]. The participants sat on a chair with their arms crossed and completed the task as quickly as possible. A duration of &#x02265;&#x02009;12&#x000a0;s indicated low physical performance according to the AWGS 2019 criteria.</p></sec><sec id="Sec7"><title>ASM measurement</title><p id="Par14">ASM, which represents the combined lean muscle mass of the upper and lower limbs, was measured via bioelectrical impedance analysis (BIA) with a dual-frequency body composition monitor (Tanita RD-545, Tanita Corporation, Tokyo, Japan). The Tanita RD-545 model is recognized for its reliability and validity in determining ASM among older Thai adults [<xref ref-type="bibr" rid="CR20">20</xref>]. The participants stood barefoot on the metal footpads while holding the device with extended arms. We used height-adjusted ASM values, with cutoffs of &#x0003c;&#x02009;7.0&#x000a0;kg/m<sup>2</sup> for men and &#x0003c;&#x02009;5.7&#x000a0;kg/m<sup>2</sup> for women, to define low muscle mass according to the AWGS 2019 criteria.</p></sec><sec id="Sec8"><title>SARC-F questionnaire</title><p id="Par15">The SARC-F questionnaire includes five components: strength (S), assistance in walking (A), rise from a chair (R), climb stairs (C), and fall (F), reflecting health status changes associated with sarcopenia. Each component is scored from 0 to 2, resulting in a total score ranging from 0 to 10, with scores of &#x02265;&#x02009;4 considered abnormal. The Thai version of the SARC-F questionnaire has been validated for use in Thai older adults [<xref ref-type="bibr" rid="CR5">5</xref>].</p></sec><sec id="Sec9"><title>Calf circumference measurement</title><p id="Par16">Calf circumference was measured with nonelastic tape while the participant stood with relaxed legs [<xref ref-type="bibr" rid="CR21">21</xref>]. To minimize the impact of leg edema on measurement accuracy, measurements were taken in the morning. The measurement was taken at the widest part of the calf, parallel to the floor. An abnormal calf circumference was defined as &#x0003c;&#x02009;34&#x000a0;cm for males and &#x0003c;&#x02009;33&#x000a0;cm for females, according to the AWGS 2019 criteria [<xref ref-type="bibr" rid="CR22">22</xref>].</p></sec><sec id="Sec10"><title>SARC-CalF questionnaire</title><p id="Par17">The SARC-CalF integrates the SARC-F score with calf circumference as a trigger for case finding. If the calf circumference was below the cutoff value, 10 points were added to the SARC-F score. The SARC-CalF score ranges from 0 to 20, with a score of &#x02265;&#x02009;11 considered abnormal for sarcopenia screening [<xref ref-type="bibr" rid="CR23">23</xref>].</p></sec><sec id="Sec11"><title>Statistical analysis</title><p id="Par18">Continuous variables are reported as means and standard deviations for normally distributed data or medians and interquartile ranges for nonnormally distributed data. The normality of each variable was assessed using the Shapiro&#x02013;Wilk test. Categorical variables are presented as numbers and percentages. The chi-squared test was used for comparisons between groups. The sensitivity, specificity, positive predictive value, negative predictive value, and area under the receiver operating characteristic curve (AUC) were calculated for the SARC-F, SARC-CalF, and calf circumference, using the AWGS 2019 criteria as the reference standard. The Youden J statistic was used to determine the optimal cutoff point for screening, with an AUC greater than 0.75 indicating clinical relevance by maximizing the sum of sensitivity and specificity [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>].</p><p id="Par19">The DeLong and McNemar statistics were used to compare the AUC, sensitivity, specificity, and accuracy between the optimal and AWGS 2019 cutoff values [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. A <italic>p-</italic>value of &#x0003c;&#x02009;0.05 was considered to indicate statistical significance. Analyses were performed with IBM SPSS Statistics, version 23 (IBM Corp, Armonk, NY, USA).</p></sec></sec><sec id="Sec12"><title>Results</title><sec id="Sec13"><title>Study population</title><p id="Par20">A total of 2543 participants aged 60 years and above were enrolled in the Thai Musculoskeletal Diseases Nationwide Study. Of these, 2455 participants provided complete data for analysis. Among the participants with complete data, 445 were diagnosed with sarcopenia, representing a prevalence of 18.1% <bold>(</bold>Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref><bold>)</bold>. Most participants were female (63.6%), with a mean age of 69&#x02009;&#x000b1;&#x02009;6.1 years.</p><p id="Par21">
<fig id="Fig1"><label>Fig. 1</label><caption><p>Flowchart of participant selection and diagnostic categorization for sarcopenia screening and diagnosis based on AWGS 2019 criteria;</p><p>Abbreviations: DF-BIA&#x02009;=&#x02009;dual-frequency bioelectrical impedance analysis</p></caption><graphic xlink:href="12877_2024_5637_Fig1_HTML" id="d33e344"/></fig>
</p><p id="Par22">Statistically significant differences were observed between the SARC-F&#x02009;&#x0003c;&#x02009;4 and SARC-F&#x02009;&#x02265;&#x02009;4 groups in variables such as sex, age, body mass index, Charlson comorbidity index, current smoking history, handgrip strength, ASM, 5TSTS, time-up-and-go test, and fall history. No statistically significant differences were found regarding underlying diseases (chronic obstructive pulmonary disease, diabetes mellitus, or heart failure), history of alcohol use, or percentage of individuals with a suboptimal calf circumference (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>).</p><p id="Par23">
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Participant demographics data and clinical characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Demographic data and performance tests</th><th align="left">Total<break/>(<italic>N</italic>&#x02009;=&#x02009;2455)</th><th align="left">SARC-F&#x02009;&#x0003c;&#x02009;4<break/>(<italic>n</italic>&#x02009;=&#x02009;2009)</th><th align="left">SARC-F &#x02265;4<break/>(<italic>n</italic>&#x02009;=&#x02009;446)</th><th align="left"><italic>p</italic>-value</th></tr></thead><tbody><tr><td align="left">Female, n (%)</td><td align="left">1562 (63.6%)</td><td align="left">1185 (59.0%)</td><td align="left">377 (84.5%)</td><td align="left">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">Age, year, mean&#x000a0;&#x000b1;&#x000a0;SD</td><td align="left">69.0&#x02009;&#x000b1;&#x02009;6.1</td><td align="left">68.6&#x02009;&#x000b1;&#x02009;5.8</td><td align="left">70.7&#x02009;&#x000b1;&#x02009;7.0</td><td align="left">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">Body mass index, kg/m<sup>2</sup>, n (%)</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left"><p>- &#x0003c;&#x02009;18.5</p><p>- 18.5&#x02013;24.9</p><p>- &#x02265;25.0</p></td><td align="left"><p>197 (8.0%)</p><p>1,279 (52.1%)</p><p>979 (39.9%)</p></td><td align="left"><p>156 (7.8%)</p><p>1,072 (53.4%)</p><p>781 (38.9%)</p></td><td align="left"><p>41 (9.2%)</p><p>207 (46.4%)</p><p>198 (44.4%)</p></td><td align="left">0.029</td></tr><tr><td align="left">Charlson comorbidity index, n (%)</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left"><p>- 1&#x02013;2</p><p>- 3&#x02013;4</p><p>- &#x02265;5</p></td><td align="left"><p>872 (35.5%)</p><p>1,368 (55.7%)</p><p>215 (8.8%)</p></td><td align="left"><p>757 (37.7%)</p><p>1,094 (54.5%)</p><p>158 (7.9%)</p></td><td align="left"><p>115 (25.8%)</p><p>274 (61.4%)</p><p>57 (12.8%)</p></td><td align="left">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">Chronic obstructive pulmonary disease, n (%)</td><td align="left">51 (2.1%)</td><td align="left">46 (2.3%)</td><td align="left">5 (1.1%)</td><td align="left">0.142</td></tr><tr><td align="left">Diabetes mellitus, n (%)</td><td align="left">438 (17.8%)</td><td align="left">347 (17.3%)</td><td align="left">91 (20.4%)</td><td align="left">0.132</td></tr><tr><td align="left">Heart failure, n (%)</td><td align="left">19 (0.8%)</td><td align="left">14 (0.7%)</td><td align="left">5 (1.1%)</td><td align="left">0.368</td></tr><tr><td align="left">Suboptimal calf circumference, n (%)</td><td align="left">1,203 (49.0%)</td><td align="left">969 (48.2%)</td><td align="left">234 (52.5%)</td><td align="left">0.116</td></tr><tr><td align="left">Current smoking, n (%)</td><td align="left">305 (12.4%)</td><td align="left">282 (14.0%)</td><td align="left">23 (5.2%)</td><td align="left">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">Alcohol (&#x02265;&#x02009;3 units/day), n (%)</td><td align="left">147 (6.0%)</td><td align="left">127 (6.3%)</td><td align="left">20 (4.5%)</td><td align="left">0.152</td></tr><tr><td align="left">Total lean mass, kg, mean&#x02009;&#x000b1;&#x02009;SD</td><td align="left">37.9&#x02009;&#x000b1;&#x02009;7.1</td><td align="left">38.6&#x02009;&#x000b1;&#x02009;7.2</td><td align="left">34.6&#x02009;&#x000b1;&#x02009;5.5</td><td align="left">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">ASM, kg,&#x000a0;mean&#x02009;&#x000b1;&#x02009;SD</td><td align="left">17.3&#x02009;&#x000b1;&#x02009;4.0</td><td align="left">17.7&#x02009;&#x000b1;&#x02009;4.1</td><td align="left">15.7&#x02009;&#x000b1;&#x02009;3.3</td><td align="left">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">ASM/height<sup>2</sup>,&#x000a0;kg/m<sup>2</sup>,&#x000a0;mean&#x02009;&#x000b1;&#x02009;SD</td><td align="left">7.1&#x02009;&#x000b1;&#x02009;1.2</td><td align="left">7.1&#x02009;&#x000b1;&#x02009;1.2</td><td align="left">6.7&#x02009;&#x000b1;&#x02009;1.1</td><td align="left">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">Hand-grip strength, kg,&#x000a0;mean&#x02009;&#x000b1;&#x02009;SD</td><td align="left">21.9&#x02009;&#x000b1;&#x02009;7.0</td><td align="left">22.9&#x02009;&#x000b1;&#x02009;6.9</td><td align="left">17.2&#x02009;&#x000b1;&#x02009;5.0</td><td align="left">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">Gait speed, m/s,&#x000a0;mean&#x02009;&#x000b1;&#x02009;SD</td><td align="left">0.9&#x02009;&#x000b1;&#x02009;0.2</td><td align="left">0.9&#x02009;&#x000b1;&#x02009;0.2</td><td align="left">0.8&#x02009;&#x000b1;&#x02009;0.2</td><td align="left">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">Timed up-and-go test, s,&#x000a0;mean&#x02009;&#x000b1;&#x02009;SD</td><td align="left">11.7&#x02009;&#x000b1;&#x02009;3.7</td><td align="left">11.0&#x02009;&#x000b1;&#x02009;2.9</td><td align="left">14.9&#x02009;&#x000b1;&#x02009;5.1</td><td align="left">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">Five-time sit-to-stand test, s,&#x000a0;mean&#x02009;&#x000b1;&#x02009;SD</td><td align="left">16.3&#x02009;&#x000b1;&#x02009;4.8</td><td align="left">15.6&#x02009;&#x000b1;&#x02009;4.2</td><td align="left">19.8&#x02009;&#x000b1;&#x02009;5.8</td><td align="left">&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">History of falling, n (%)</td><td align="left">539 (22.0%)</td><td align="left">367 (18.3%)</td><td align="left">172 (38.6%)</td><td align="left">&#x0003c;&#x02009;0.001</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: ASM&#x02009;=&#x02009;appendicular skeletal mass; SD&#x02009;=&#x02009;standard deviation</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec14"><title>Screening for possible sarcopenia</title><p id="Par24">The SARC-F and SARC-CalF tools exhibited high sensitivity rates for screening for possible sarcopenia, with SARC-F reaching 99.8% (95% CI 98.8&#x02013;99.9) and SARC-CalF achieving 98.8% (95% CI 96.9&#x02013;99.7). In contrast, the sensitivity of the AWGS 2019 criteria, which are based on calf circumference, was considerably lower at 52.4% (95% CI 48.9&#x02013;55.9) for males and 47.8% (95% CI 45.3&#x02013;50.4) for females (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>).</p><p id="Par25">
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Diagnostic performance of SARC-F, SARC-CalF, and calf circumference for screening possible sarcopenia</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="2">Screening tests</th><th align="left">AUC<break/>(95% CI)</th><th align="left">Sensitivity<break/>% (95% CI)</th><th align="left">Specificity<break/>% (95% CI)</th><th align="left">PPV<break/>% (95% CI)</th><th align="left">NPV<break/>% (95% CI)</th></tr></thead><tbody><tr><td align="left" colspan="2"><p>SARC-F</p><p>(&#x02265;&#x02009;4)</p></td><td align="left"><p>0.718</p><p>(0.684&#x02013;0.752)</p></td><td align="left"><p>99.8</p><p>(98.8&#x02013;99.9)</p></td><td align="left"><p>7.6</p><p>(6.5&#x02013;8.9)</p></td><td align="left"><p>19.3</p><p>(19.1&#x02013;19.6)</p></td><td align="left"><p>99.4</p><p>(95.6&#x02013;99.9)</p></td></tr><tr><td align="left" rowspan="2">AWGS 2019 calf circumference</td><td align="left"><p>Male</p><p>(&#x0003c;&#x02009;34&#x000a0;cm)</p></td><td align="left"><p>0.528</p><p>(0.471&#x02013;0.585)</p></td><td align="left"><p>52.4</p><p>(48.9&#x02013;55.9)</p></td><td align="left"><p>52.8</p><p>(42.0-63.3)</p></td><td align="left"><p>90.7</p><p>(88.6&#x02013;92.5)</p></td><td align="left"><p>11.2</p><p>(9.3&#x02013;13.4)</p></td></tr><tr><td align="left"><p>Female</p><p>(&#x0003c;&#x02009;33&#x000a0;cm)</p></td><td align="left"><p>0.565</p><p>(0.503&#x02013;0.627)</p></td><td align="left"><p>47.8</p><p>(45.3&#x02013;50.4)</p></td><td align="left"><p>63.5</p><p>(50.4&#x02013;75.3)</p></td><td align="left"><p>96.9</p><p>(95.7&#x02013;97.8)</p></td><td align="left"><p>4.9</p><p>(4.1&#x02013;5.8)</p></td></tr><tr><td align="left" colspan="2"><p>SARC-CalF</p><p>(&#x02265;&#x02009;11)</p></td><td align="left"><p>0.712</p><p>(0.672&#x02013;0.752)</p></td><td align="left"><p>98.8</p><p>(96.9&#x02013;99.7)</p></td><td align="left"><p>7.1</p><p>(6.0-8.2)</p></td><td align="left"><p>14.3</p><p>(14.1&#x02013;14.5)</p></td><td align="left"><p>97.4</p><p>(93.3&#x02013;99.0)</p></td></tr><tr><td align="left" rowspan="2">New cut-off calf circumference</td><td align="left"><p>Male</p><p>(&#x0003c;&#x02009;33&#x000a0;cm)</p></td><td align="left"><p>0.526</p><p>(0.463&#x02013;0.588)</p></td><td align="left"><p>37.5</p><p>(34.2&#x02013;41.0)</p></td><td align="left"><p>68.1</p><p>(57.5&#x02013;77.5)</p></td><td align="left"><p>91.2</p><p>(88.4&#x02013;93.4)</p></td><td align="left"><p>11</p><p>(9.6&#x02013;12.6)</p></td></tr><tr><td align="left"><p>Female</p><p>(&#x0003c;&#x02009;31&#x000a0;cm)</p></td><td align="left"><p>0.557</p><p>(0.486&#x02013;0.628)</p></td><td align="left"><p>30.5</p><p>(28.2&#x02013;32.9)</p></td><td align="left"><p>82.5</p><p>(70.9&#x02013;91.0)</p></td><td align="left"><p>97.7</p><p>(96.0-98.6)</p></td><td align="left"><p>4.8</p><p>(4.2&#x02013;5.3)</p></td></tr><tr><td align="left" colspan="2"><p>Revised SARC-CalF</p><p>(&#x02265;&#x02009;11)</p></td><td align="left"><p>0.666</p><p>(0.620&#x02013;0.712)</p></td><td align="left"><p>19.3</p><p>(17.7&#x02013;21.0)</p></td><td align="left"><p>93.5</p><p>(88.4&#x02013;96.8)</p></td><td align="left"><p>97.8</p><p>(96.1&#x02013;98.8)</p></td><td align="left"><p>7.2</p><p>(6.9&#x02013;7.5)</p></td></tr></tbody></table><table-wrap-foot><p>Abbreviations: AUC&#x02009;=&#x02009;area under the receiver operating characteristic curve; CI&#x02009;=&#x02009;confidence interval; NPV&#x02009;=&#x02009;negative predictive value; PPV&#x02009;=&#x02009;positive predictive value</p></table-wrap-foot></table-wrap>
</p><p id="Par26">However, the AUC values were 0.718 (95% CI 0.684&#x02013;0.752) for the SARC-F and 0.712 (95% CI 0.672&#x02013;0.752) for the SARC-CalF. The AUC values for calf circumference were 0.528 (95% CI 0.471&#x02013;0.585) in males and 0.565 (95% CI 0.503&#x02013;0.627) in females. The low AUC values across all three measures indicate limited clinical utility (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>).</p><p id="Par27">
<fig id="Fig2"><label>Fig. 2</label><caption><p>Receiver operating characteristic curves for detecting possible sarcopenia: <bold>(A)</bold> SARC-F and SARC-CalF questionnaires and <bold>(B)</bold> calf circumference measurements</p></caption><graphic xlink:href="12877_2024_5637_Fig2_HTML" id="d33e837"/></fig>
</p></sec><sec id="Sec15"><title>Effect of new cutoff scores on screening accuracy for possible Sarcopenia</title><p id="Par28">The new cutoff scores derived from our study participants, defined by the maximum Youden index, were applied, and the calf circumference thresholds were set at &#x0003c;&#x02009;33&#x000a0;cm for males and &#x0003c;&#x02009;31&#x000a0;cm for females. These revised thresholds were integrated into the SARC-F to evaluate a modified SARC-CalF. However, the AUCs for both the new calf circumference cutoff and the revised SARC-CalF did not indicate a significant increase in screening performance for possible sarcopenia (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>).</p></sec><sec id="Sec16"><title>Diagnostic performance for Sarcopenia</title><p id="Par29">Calf circumference demonstrated high sensitivity for diagnosing sarcopenia, with values of 93.3% (95% CI 89.3&#x02013;96.1) in males and 91.4% (95% CI 86.7&#x02013;94.8) in females. The specificity was moderate, reaching 63.1% (95% CI 59.3&#x02013;66.8) in males and 59.4% (95% CI 56.7&#x02013;62.0) in females. The AUC was 0.897 (95% CI: 0.874&#x02013;0.920) for males and 0.878 (95% CI: 0.852&#x02013;0.904) for females, suggesting high diagnostic accuracy and clinical utility (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>).</p><p id="Par30">
<fig id="Fig3"><label>Fig. 3</label><caption><p>Receiver operating characteristic curves for diagnosing sarcopenia: <bold>(A)</bold> SARC-F and SARC-CalF questionnaires and <bold>(B)</bold> calf circumference measurements</p></caption><graphic xlink:href="12877_2024_5637_Fig3_HTML" id="d33e868"/></fig>
</p><p id="Par31">Compared with calf circumference, the SARC-F showed much lower sensitivity (21.1%, 95% CI 17.4&#x02013;25.2) but higher specificity (82.5%, 95% CI 80.8&#x02013;84.2). The SARC-CalF exhibited a low sensitivity of 38.7% (95% CI 34.1&#x02013;43.4) and a high specificity of 92% (95% CI 90.8&#x02013;93.2). The AUC values for the SARC-F and SARC-CalF were 0.508 (95% CI 0.477&#x02013;0.538) and 0.729 (95% CI 0.699&#x02013;0.759), respectively, indicating limited clinical utility (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>).</p><p id="Par32">
<table-wrap id="Tab3"><label>Table 3</label><caption><p>Diagnostic performance of SARC-F, SARC-CalF, and calf circumference for diagnosing sarcopenia</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="2">Screening tests</th><th align="left">AUC<break/>(95% CI)</th><th align="left">Sensitivity<break/>% (95% CI)</th><th align="left">Specificity<break/>% (95% CI)</th><th align="left">PPV<break/>% (95% CI)</th><th align="left">NPV<break/>% (95% CI)</th></tr></thead><tbody><tr><td align="left" colspan="2"><p>SARC-F</p><p>(&#x02265;&#x02009;4)</p></td><td align="left"><p>0.508</p><p>(0.477&#x02013;0.538)</p></td><td align="left"><p>21.1</p><p>(17.4&#x02013;25.2)</p></td><td align="left"><p>82.5</p><p>(80.8&#x02013;84.2)</p></td><td align="left"><p>21.1</p><p>(17.9&#x02013;24.7)</p></td><td align="left"><p>82.5</p><p>(81.7&#x02013;83.2)</p></td></tr><tr><td align="left" rowspan="2">AWGS 2019 calf circumference</td><td align="left"><p>Male</p><p>(&#x0003c;&#x02009;34&#x000a0;cm)</p></td><td align="left"><p>0.897</p><p>(0.874&#x02013;0.920)</p></td><td align="left"><p>93.3</p><p>(89.3&#x02013;96.1)</p></td><td align="left"><p>63.1</p><p>(59.3&#x02013;66.8)</p></td><td align="left"><p>47.7</p><p>(45.1&#x02013;50.4)</p></td><td align="left"><p>96.3</p><p>(94.1&#x02013;97.7)</p></td></tr><tr><td align="left"><p>Female</p><p>(&#x0003c;&#x02009;33&#x000a0;cm)</p></td><td align="left"><p>0.878</p><p>(0.852&#x02013;0.904)</p></td><td align="left"><p>91.4</p><p>(86.7&#x02013;94.8)</p></td><td align="left"><p>59.4</p><p>(56.7&#x02013;62.0)</p></td><td align="left"><p>25.7</p><p>(24.2&#x02013;27.2)</p></td><td align="left"><p>97.8</p><p>(96.6&#x02013;98.6)</p></td></tr><tr><td align="left" colspan="2"><p>SARC-CalF</p><p>(&#x02265;&#x02009;11)</p></td><td align="left"><p>0.729</p><p>(0.699&#x02013;0.759)</p></td><td align="left"><p>38.7</p><p>(34.1&#x02013;43.4)</p></td><td align="left"><p>92</p><p>(90.8&#x02013;93.2)</p></td><td align="left"><p>51.8</p><p>(47.1&#x02013;56.5)</p></td><td align="left"><p>87.1</p><p>(86.3&#x02013;88.0)</p></td></tr><tr><td align="left" rowspan="2">New cut-off calf circumference</td><td align="left"><p>Male</p><p>(&#x0003c;&#x02009;33&#x000a0;cm)</p></td><td align="left"><p>0.823</p><p>(0.791&#x02013;0.855)</p></td><td align="left"><p>84.4</p><p>(79.1&#x02013;88.8)</p></td><td align="left"><p>80.2</p><p>(76.9&#x02013;83.2)</p></td><td align="left"><p>60.6</p><p>(56.7&#x02013;64.4)</p></td><td align="left"><p>93.4</p><p>(91.3&#x02013;95.0)</p></td></tr><tr><td align="left"><p>Female</p><p>(&#x0003c;&#x02009;31&#x000a0;cm)</p></td><td align="left"><p>0.804</p><p>(0.770&#x02013;0.839)</p></td><td align="left"><p>77.9</p><p>(71.6&#x02013;83.3)</p></td><td align="left"><p>83</p><p>(80.9&#x02013;85.0)</p></td><td align="left"><p>41.3</p><p>(38.0-44.7)</p></td><td align="left"><p>96.1</p><p>(95.0-96.9)</p></td></tr><tr><td align="left" colspan="2"><p>Revised SARC-CalF</p><p>(&#x02265;&#x02009;11)</p></td><td align="left"><p>0.798</p><p>(0.774&#x02013;0.822)</p></td><td align="left"><p>47</p><p>(42.3&#x02013;51.7)</p></td><td align="left"><p>87.8</p><p>(86.3&#x02013;89.2)</p></td><td align="left"><p>46.0</p><p>(42.3&#x02013;49.9)</p></td><td align="left"><p>88.2</p><p>(87.3&#x02013;89.1)</p></td></tr></tbody></table><table-wrap-foot><p>Abbreviations: AUC&#x02009;=&#x02009;area under the receiver operating characteristic curve; CI&#x02009;=&#x02009;confidence interval; NPV&#x02009;=&#x02009;negative predictive value; PPV&#x02009;=&#x02009;positive predictive value</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec17"><title>Impact of new cutoff scores on diagnostic performance for Sarcopenia</title><p id="Par33">When the new cutoff scores defined by the maximum Youden index were applied for diagnosing sarcopenia (&#x0003c;&#x02009;33&#x000a0;cm for males and &#x0003c;&#x02009;31&#x000a0;cm for females), the sensitivity slightly decrease to 84.4% (95% CI 79.1&#x02013;88.8) for males and 77.9% (95% CI 71.6&#x02013;83.3) for females. However, the specificity improved, reaching 80.2% (95% CI 76.9&#x02013;83.2) in males and 83% (95% CI 80.9&#x02013;85.0) in females. Although the AUC values slightly decreased to 0.823 for males and 0.804 for females, they remained above 0.75, indicating clinical relevance. Furthermore, the newly established cutoffs demonstrated significantly improved overall diagnostic accuracy for detecting sarcopenia compared to the criteria outlined in the AWGS 2019 guidelines (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>).</p><p id="Par34">
<table-wrap id="Tab4"><label>Table 4</label><caption><p>Comparison of diagnostic performance between AWGS 2019 and new calf circumference cutoff values for sarcopenia diagnosis</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Diagnostic performance</th><th align="left">AWGS 2019 cutoff value<break/>(&#x0003c;&#x02009;34&#x000a0;cm for males and<break/>&#x02009;&#x0003c;&#x02009;33&#x000a0;cm for females)</th><th align="left">New cutoff value<break/>(&#x0003c;&#x02009;33&#x000a0;cm for males and<break/>&#x02009;&#x0003c;&#x02009;31&#x000a0;cm for females)</th><th align="left"><italic>p</italic>-value</th></tr></thead><tbody><tr><td align="left"><p>AUC [SE] (male)</p><p>AUC [SE] (female)</p><p>Sensitivity</p></td><td align="left"><p>0.897 [0.012]</p><p>0.878 [0.013]</p><p>92.4% (89.5-94.7%)</p></td><td align="left"><p>0.823 [0.012]</p><p>0.804 [0.013]</p><p>81.4% (77.4-84.9%)</p></td><td align="left"><p>&#x0003c;&#x02009;0.001*</p><p>&#x0003c;&#x02009;0.001*</p><p>&#x0003c;&#x02009;0.001**</p></td></tr><tr><td align="left">Specificity</td><td align="left">60.6% (58.4-62.7%)</td><td align="left">82.1% (80.3-83.7%)</td><td align="left">&#x0003c;&#x02009;0.001**</td></tr><tr><td align="left">Accuracy</td><td align="left">66.4% (64.5-68.2%)</td><td align="left">82.0% (80.4-83.5%)</td><td align="left">&#x0003c;&#x02009;0.001**</td></tr></tbody></table><table-wrap-foot><p>* DeLong&#x02019;s test for AUC comparisons</p><p>** McNemar&#x02019;s test for other diagnostic performance comparisons</p><p>Abbreviations: AUC&#x02009;=&#x02009;area under the receiver operating characteristic curve; SE&#x02009;=&#x02009;standard error</p></table-wrap-foot></table-wrap>
</p></sec></sec><sec id="Sec18"><title>Discussion</title><p id="Par35">Sarcopenia is characterized by the progressive loss of skeletal muscle mass with age. It is a critical concern because of its strong associations with reduced physical function, increased risk of falls, and a higher incidence of fractures, especially among the elderly population [<xref ref-type="bibr" rid="CR28">28</xref>].</p><p id="Par36">
Our study revealed that the prevalence of sarcopenia among community-dwelling older adults in Thailand is 18.1%, which is relatively high compared with the 10&#x02013;16% prevalence reported in elderly populations from other countries [<xref ref-type="bibr" rid="CR29">29</xref>]. This discrepancy may result from differences in diagnostic methods and variations in the demographic groups studied. Given the associated risks, effective screening for sarcopenia is essential to prevent related complications. However, our findings suggest that the SARC-F and SARC-CalF questionnaires are not sufficiently effective for detecting sarcopenia in elderly individuals. In contrast, calf circumference measurement alone appears to be a more reliable indicator for this purpose.</p><p id="Par37">While the SARC-F and SARC-CalF questionnaires demonstrated high sensitivity as tools for identifying possible sarcopenia, their sensitivity for confirming actual sarcopenia was much lower. This outcome aligns with our finding that 93.7% of individuals classified as having possible sarcopenia were confirmed to have the condition, whereas only 19.3% had sarcopenia (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). These findings suggest that the SARC-F and SARC-CalF questionnaires are useful for initial screening in primary healthcare or community preventive settings. However, further evaluation with tools such as a hand dynamometer or physical performance tests may still be necessary for individuals with abnormal scores. Nevertheless, conducting additional tests can be challenging in settings lacking the required equipment or trained personnel, potentially leading to unnecessary referrals for muscle mass measurement.</p><p id="Par38">Our findings are consistent with those of previous studies showing that the SARC-F has low sensitivity but high specificity for diagnosing sarcopenia [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. This characteristic may be because the questionnaire&#x02019;s items are more relevant to elderly individuals who are severely frail than to those who are relatively strong. Additionally, none of the questions directly assess muscle mass, a critical criterion in the diagnosis of sarcopenia.</p><p id="Par39">Our study suggests that calf circumference may be a more effective tool than the SARC-F and SARC-CalF questionnaires for both screening and diagnosing sarcopenia. This conclusion is supported by its AUC value being greater than 0.75, which is considered clinically significant. Calf circumference, as an anthropometric measure, reflects factors such as nutritional status, body mass index, and muscle mass, all of which are recognized risk factors for the development of sarcopenia [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>].</p><p id="Par40">A previous study demonstrated a strong correlation between calf circumference and calf muscle mass in elderly individuals, with correlation coefficients of <italic>r</italic>&#x02009;=&#x02009;0.908 in males and <italic>r</italic>&#x02009;=&#x02009;0.892 in females, both with <italic>p</italic>-values of &#x0003c;&#x02009;0.05 [<xref ref-type="bibr" rid="CR34">34</xref>]. ASM, which includes calf muscle mass, is a key diagnostic criterion for sarcopenia. Adjusting the cutoff point for calf circumference to &#x0003c;&#x02009;31&#x000a0;cm for females and &#x0003c;&#x02009;33&#x000a0;cm for males increased the specificity from 60.6 to 82.1%, with only a slight decrease in sensitivity from 92.4 to 81.4%. However, the overall accuracy improved from 66.4 to 82%. This approach may be particularly suitable for screening for sarcopenia, especially in settings where advanced diagnostic tools such as BIA or dual-energy X-ray absorptiometry are not readily available. Additionally, since sarcopenia is not an immediately life-threatening condition, it may be acceptable if some cases are missed during the screening process [<xref ref-type="bibr" rid="CR35">35</xref>].</p><p id="Par41">
To improve the accuracy of the SARC-F questionnaire, incorporating additional parameters that reflect muscle quantity may be necessary. For example, adding factors such as age, arm circumference, and body mass index&#x02014;parameters shown in previous studies to enhance screening accuracy&#x02014;could be beneficial [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. This approach aligns with our findings that including calf circumference improves the sensitivity and specificity of sarcopenia screening. However, for community-level screening, measuring calf circumference remains a practical option. It is a simple, noninvasive, and inexpensive tool that can be used in various settings. Additionally, studies have demonstrated a positive correlation between calf circumference and muscle mass measured by both BIA and dual-energy X-ray absorptiometry, regardless of factors such as obesity and age [<xref ref-type="bibr" rid="CR38">38</xref>]. Therefore, calf circumference measurement is likely the most suitable method for large-scale population screening.</p><p id="Par42">
The strength of this study lies in its distinction as the first large-scale national investigation of sarcopenia in Thailand. The sample included older adults aged 60 years and above from community settings, and it encompassed all six geographically diverse regions of the country. Moreover, this study is the first to show that the SARC-F and SARC-CalF screening questionnaires are not clinically effective. In contrast, we identified calf circumference as the most effective method for sarcopenia screening. Highlighting calf circumference as a reliable and cost-effective tool is particularly beneficial for large-scale or resource-limited settings. This approach has led to the establishment of a new national cutoff point for low calf circumference, specifically tailored to Thai older adults.</p><p id="Par43">However, there are limitations to consider. The measurement of calf circumference may not fully account for the influence of adipose tissue and limb edema, which could affect the accuracy of the assessment. Additionally, the use of BIA instead of dual-energy X-ray absorptiometry may have introduced variability due to differences in participant hydration levels, potentially impacting the reliability of muscle mass measurements.</p></sec><sec id="Sec19"><title>Conclusions</title><p id="Par44">The prevalence of sarcopenia in Thailand is relatively high. The SARC-F questionnaire has proven ineffective for diagnosing sarcopenia, whereas calf circumference has been shown to be effective as a screening tool. The incorporation of additional parameters into the SARC-F questionnaire may enhance its diagnostic accuracy, but further research is needed to validate this approach.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We thank the staff at the subdistrict health promotion hospital and subdistrict administrative organization, as well as Ms. Wachirapan Narktang and Mr. Pongsathorn Samphaotong, for their assistance in data compilation and statistical analysis. We also express our gratitude to all the study participants for their cooperation.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>EV and PL were responsible for study conception, project administration, supervision, methodology, and investigation. EV, AU, PC, NA, AA and PL contributed to the study design, data collection, statistical analysis, manuscript drafting, review, and editing. AU, PC, NA, and AA played a crucial role as the essentially intellectual contributors to this study. EV and PL reviewed and edited the final manuscript. All the authors read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Open access funding provided by Mahidol University. The National Research Council of Thailand funded this study. The funder did not influence the study design, data collection, analysis, interpretation, or publication decision.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>The data supporting this study&#x02019;s findings are available from the corresponding author upon reasonable request. The data are not publicly available due to privacy or ethical restrictions.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par45">This study was conducted per the Declaration of Helsinki and received ethical approval from the Siriraj Institutional Review Board, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand (COA-715/2024). Trained research assistants obtained written informed consent from all participants before their enrollment.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par46">Not applicable.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par47">The authors declare no competing interests.</p></notes></notes><glossary><title>Abbreviations</title><def-list><def-item><term>AWGS</term><def><p id="Par48">Asian Working Group for Sarcopenia</p></def></def-item><def-item><term>ASM</term><def><p id="Par49">Appendicular skeletal muscle mass</p></def></def-item><def-item><term>5TSTS</term><def><p id="Par50">Five-time sit-to-stand</p></def></def-item><def-item><term>BIA</term><def><p id="Par51">Bioelectrical impedance analysis</p></def></def-item><def-item><term>AUC</term><def><p id="Par52">Area under the receiver operating characteristic curve</p></def></def-item></def-list></glossary><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Albert</surname><given-names>SG</given-names></name><name><surname>Wood</surname><given-names>E</given-names></name></person-group><article-title>Meta-analysis of clinical fracture risk reduction of antiosteoporosis drugs: direct and indirect comparisons and Meta-regressions</article-title><source>Endocr Pract</source><year>2021</year><volume>27</volume><issue>11</issue><fpage>1082</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.eprac.2021.06.015</pub-id><pub-id pub-id-type="pmid">34252583</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Albert SG, Wood E. Meta-analysis of clinical fracture risk reduction of antiosteoporosis drugs: direct and indirect comparisons and Meta-regressions. Endocr Pract. 2021;27(11):1082&#x02013;92.<pub-id pub-id-type="pmid">34252583</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Yeung</surname><given-names>SSY</given-names></name><name><surname>Reijnierse</surname><given-names>EM</given-names></name><name><surname>Pham</surname><given-names>VK</given-names></name><name><surname>Trappenburg</surname><given-names>MC</given-names></name><name><surname>Lim</surname><given-names>WK</given-names></name><name><surname>Meskers</surname><given-names>CGM</given-names></name><etal/></person-group><article-title>Sarcopenia and its association with falls and fractures in older adults: a systematic review and meta-analysis</article-title><source>J Cachexia Sarcopenia Muscle</source><year>2019</year><volume>10</volume><issue>3</issue><fpage>485</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1002/jcsm.12411</pub-id><pub-id pub-id-type="pmid">30993881</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Yeung SSY, Reijnierse EM, Pham VK, Trappenburg MC, Lim WK, Meskers CGM, et al. Sarcopenia and its association with falls and fractures in older adults: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2019;10(3):485&#x02013;500.<pub-id pub-id-type="pmid">30993881</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Veronese</surname><given-names>N</given-names></name><name><surname>Smith</surname><given-names>L</given-names></name><name><surname>Barbagallo</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Zou</surname><given-names>L</given-names></name><name><surname>Haro</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Sarcopenia and fall-related injury among older adults in five low- and middle-income countries</article-title><source>Exp Gerontol</source><year>2021</year><volume>147</volume><fpage>111262</fpage><pub-id pub-id-type="doi">10.1016/j.exger.2021.111262</pub-id><pub-id pub-id-type="pmid">33516908</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Veronese N, Smith L, Barbagallo M, Yang L, Zou L, Haro JM, et al. Sarcopenia and fall-related injury among older adults in five low- and middle-income countries. Exp Gerontol. 2021;147:111262.<pub-id pub-id-type="pmid">33516908</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Yilmaz</surname><given-names>O</given-names></name><name><surname>Bahat</surname><given-names>G</given-names></name></person-group><article-title>Important points to consider during practical application and in the Validation studies of SARC-F Tool to screen Sarcopenia [Letter]</article-title><source>Clin Interv Aging</source><year>2020</year><volume>15</volume><fpage>877</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.2147/CIA.S262334</pub-id><pub-id pub-id-type="pmid">32606627</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Yilmaz O, Bahat G. Important points to consider during practical application and in the Validation studies of SARC-F Tool to screen Sarcopenia [Letter]. Clin Interv Aging. 2020;15:877&#x02013;8.<pub-id pub-id-type="pmid">32606627</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Akarapornkrailert</surname><given-names>P</given-names></name><name><surname>Muangpaisan</surname><given-names>W</given-names></name><name><surname>Boonpeng</surname><given-names>A</given-names></name><name><surname>Daengdee</surname><given-names>D</given-names></name></person-group><article-title>Validation of the Thai version of SARC-F, MSRA-7, and MSRA-5 questionnaires compared to AWGS 2019 and Sarcopenia risks in older patients at a medical outpatient clinic</article-title><source>Osteoporos Sarcopenia</source><year>2020</year><volume>6</volume><issue>4</issue><fpage>205</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.afos.2020.11.006</pub-id><pub-id pub-id-type="pmid">33426310</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Akarapornkrailert P, Muangpaisan W, Boonpeng A, Daengdee D. Validation of the Thai version of SARC-F, MSRA-7, and MSRA-5 questionnaires compared to AWGS 2019 and Sarcopenia risks in older patients at a medical outpatient clinic. Osteoporos Sarcopenia. 2020;6(4):205&#x02013;11.<pub-id pub-id-type="pmid">33426310</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Imamura</surname><given-names>K</given-names></name><name><surname>Yamamoto</surname><given-names>S</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>Matsuzawa</surname><given-names>R</given-names></name><name><surname>Harada</surname><given-names>M</given-names></name><name><surname>Yoshikoshi</surname><given-names>S</given-names></name><etal/></person-group><article-title>Limitations of SARC-F as a Screening Tool for Sarcopenia in patients on Hemodialysis</article-title><source>Nephron</source><year>2022</year><volume>146</volume><issue>1</issue><fpage>32</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1159/000518810</pub-id><pub-id pub-id-type="pmid">34535597</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Imamura K, Yamamoto S, Suzuki Y, Matsuzawa R, Harada M, Yoshikoshi S, et al. Limitations of SARC-F as a Screening Tool for Sarcopenia in patients on Hemodialysis. Nephron. 2022;146(1):32&#x02013;9.<pub-id pub-id-type="pmid">34535597</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Ishida</surname><given-names>Y</given-names></name><name><surname>Maeda</surname><given-names>K</given-names></name><name><surname>Nonogaki</surname><given-names>T</given-names></name><name><surname>Shimizu</surname><given-names>A</given-names></name><name><surname>Yamanaka</surname><given-names>Y</given-names></name><name><surname>Matsuyama</surname><given-names>R</given-names></name><etal/></person-group><article-title>SARC-F as a Screening Tool for Sarcopenia and possible Sarcopenia proposed by AWGS 2019 in hospitalized older adults</article-title><source>J Nutr Health Aging</source><year>2020</year><volume>24</volume><issue>10</issue><fpage>1053</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1007/s12603-020-1462-9</pub-id><pub-id pub-id-type="pmid">33244560</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Ishida Y, Maeda K, Nonogaki T, Shimizu A, Yamanaka Y, Matsuyama R, et al. SARC-F as a Screening Tool for Sarcopenia and possible Sarcopenia proposed by AWGS 2019 in hospitalized older adults. J Nutr Health Aging. 2020;24(10):1053&#x02013;60.<pub-id pub-id-type="pmid">33244560</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Bahat</surname><given-names>G</given-names></name><name><surname>Yilmaz</surname><given-names>O</given-names></name><name><surname>K&#x00131;l&#x00131;&#x000e7;</surname><given-names>C</given-names></name><name><surname>Oren</surname><given-names>MM</given-names></name><name><surname>Karan</surname><given-names>MA</given-names></name></person-group><article-title>Performance of SARC-F in Regard to Sarcopenia definitions, muscle Mass and Functional measures</article-title><source>J Nutr Health Aging</source><year>2018</year><volume>22</volume><issue>8</issue><fpage>898</fpage><lpage>903</lpage><pub-id pub-id-type="doi">10.1007/s12603-018-1067-8</pub-id><pub-id pub-id-type="pmid">30272090</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Bahat G, Yilmaz O, K&#x00131;l&#x00131;&#x000e7; C, Oren MM, Karan MA. Performance of SARC-F in Regard to Sarcopenia definitions, muscle Mass and Functional measures. J Nutr Health Aging. 2018;22(8):898&#x02013;903.<pub-id pub-id-type="pmid">30272090</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Bahat</surname><given-names>G</given-names></name><name><surname>Yilmaz</surname><given-names>O</given-names></name><name><surname>Oren</surname><given-names>MM</given-names></name><name><surname>Karan</surname><given-names>MA</given-names></name><name><surname>Reginster</surname><given-names>JY</given-names></name><name><surname>Bruy&#x000e8;re</surname><given-names>O</given-names></name><etal/></person-group><article-title>Cross-cultural adaptation and validation of the SARC-F to assess Sarcopenia: methodological report from European Union Geriatric Medicine Society Sarcopenia Special Interest Group</article-title><source>Eur Geriatr Med</source><year>2018</year><volume>9</volume><issue>1</issue><fpage>23</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1007/s41999-017-0003-5</pub-id><pub-id pub-id-type="pmid">34654275</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Bahat G, Yilmaz O, Oren MM, Karan MA, Reginster JY, Bruy&#x000e8;re O, et al. Cross-cultural adaptation and validation of the SARC-F to assess Sarcopenia: methodological report from European Union Geriatric Medicine Society Sarcopenia Special Interest Group. Eur Geriatr Med. 2018;9(1):23&#x02013;8.<pub-id pub-id-type="pmid">34654275</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Bahat</surname><given-names>G</given-names></name><name><surname>Oren</surname><given-names>MM</given-names></name><name><surname>Yilmaz</surname><given-names>O</given-names></name><name><surname>K&#x00131;l&#x00131;&#x000e7;</surname><given-names>C</given-names></name><name><surname>Aydin</surname><given-names>K</given-names></name><name><surname>Karan</surname><given-names>MA</given-names></name></person-group><article-title>Comparing SARC-F with SARC-CalF to screen Sarcopenia in Community living older adults</article-title><source>J Nutr Health Aging</source><year>2018</year><volume>22</volume><issue>9</issue><fpage>1034</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1007/s12603-018-1072-y</pub-id><pub-id pub-id-type="pmid">30379299</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Bahat G, Oren MM, Yilmaz O, K&#x00131;l&#x00131;&#x000e7; C, Aydin K, Karan MA. Comparing SARC-F with SARC-CalF to screen Sarcopenia in Community living older adults. J Nutr Health Aging. 2018;22(9):1034&#x02013;8.<pub-id pub-id-type="pmid">30379299</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Barreto de Lima</surname><given-names>A</given-names></name><name><surname>Dos Santos Ribeiro</surname><given-names>G</given-names></name><name><surname>Henriques-Neto</surname><given-names>D</given-names></name><name><surname>R&#x000fa;bio Gouveia</surname><given-names>&#x000c9;</given-names></name><name><surname>Baptista</surname><given-names>F</given-names></name></person-group><article-title>Diagnostic performance of SARC-F and SARC-CalF in screening for Sarcopenia in older adults in Northern Brazil</article-title><source>Sci Rep</source><year>2023</year><volume>13</volume><issue>1</issue><fpage>11698</fpage><pub-id pub-id-type="doi">10.1038/s41598-023-39002-y</pub-id><pub-id pub-id-type="pmid">37474595</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Barreto de Lima A, Dos Santos Ribeiro G, Henriques-Neto D, R&#x000fa;bio Gouveia &#x000c9;, Baptista F. Diagnostic performance of SARC-F and SARC-CalF in screening for Sarcopenia in older adults in Northern Brazil. Sci Rep. 2023;13(1):11698.<pub-id pub-id-type="pmid">37474595</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>A</given-names></name><name><surname>Ishizaka</surname><given-names>M</given-names></name><name><surname>Kobayashi</surname><given-names>K</given-names></name><name><surname>Sawaya</surname><given-names>Y</given-names></name><name><surname>Hara</surname><given-names>T</given-names></name><name><surname>Nagasaka</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Changes in the screening efficacy of lower calf circumference, SARC-F score, and SARC-CalF score following update from AWGS 2014 to 2019 Sarcopenia diagnostic criteria in community-dwelling older adults</article-title><source>J Phys Ther Sci</source><year>2021</year><volume>33</volume><issue>3</issue><fpage>241</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1589/jpts.33.241</pub-id><pub-id pub-id-type="pmid">33814711</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Ito A, Ishizaka M, Kobayashi K, Sawaya Y, Hara T, Nagasaka Y, et al. Changes in the screening efficacy of lower calf circumference, SARC-F score, and SARC-CalF score following update from AWGS 2014 to 2019 Sarcopenia diagnostic criteria in community-dwelling older adults. J Phys Ther Sci. 2021;33(3):241&#x02013;5.<pub-id pub-id-type="pmid">33814711</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Mazocco</surname><given-names>L</given-names></name><name><surname>Chagas</surname></name><name><surname>Barbosa-Silva</surname></name><name><surname>Gonzalez</surname><given-names>TG</given-names></name><name><surname>CHA Schwanke</surname><given-names>MC</given-names></name></person-group><article-title>Accuracy of SARC-F and SARC-CalF for Sarcopenia screening in older women from southern Brazil</article-title><source>Nutrition</source><year>2020</year><volume>79&#x02013;80</volume><fpage>110955</fpage><pub-id pub-id-type="doi">10.1016/j.nut.2020.110955</pub-id><pub-id pub-id-type="pmid">32919183</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Mazocco L, Chagas, Barbosa-Silva, Gonzalez TG, CHA Schwanke MC. Accuracy of SARC-F and SARC-CalF for Sarcopenia screening in older women from southern Brazil. Nutrition. 2020;79&#x02013;80:110955.<pub-id pub-id-type="pmid">32919183</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Xie</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><etal/></person-group><article-title>Comparing Mini Sarcopenia Risk Assessment with SARC-F for Screening Sarcopenia in Community-Dwelling older adults</article-title><source>J Am Med Dir Assoc</source><year>2019</year><volume>20</volume><issue>1</issue><fpage>53</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.jamda.2018.04.012</pub-id><pub-id pub-id-type="pmid">29909052</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Yang M, Hu X, Xie L, Zhang L, Zhou J, Lin J, et al. Comparing Mini Sarcopenia Risk Assessment with SARC-F for Screening Sarcopenia in Community-Dwelling older adults. J Am Med Dir Assoc. 2019;20(1):53&#x02013;7.<pub-id pub-id-type="pmid">29909052</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Kiss</surname><given-names>CM</given-names></name><name><surname>Bertschi</surname><given-names>D</given-names></name><name><surname>Beerli</surname><given-names>N</given-names></name><name><surname>Berres</surname><given-names>M</given-names></name><name><surname>Kressig</surname><given-names>RW</given-names></name><name><surname>Fischer</surname><given-names>AM</given-names></name></person-group><article-title>Calf circumference as a surrogate indicator for detecting low muscle mass in hospitalized geriatric patients</article-title><source>Aging Clin Exp Res</source><year>2024</year><volume>36</volume><issue>1</issue><fpage>25</fpage><pub-id pub-id-type="doi">10.1007/s40520-024-02694-x</pub-id><pub-id pub-id-type="pmid">38321234</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Kiss CM, Bertschi D, Beerli N, Berres M, Kressig RW, Fischer AM. Calf circumference as a surrogate indicator for detecting low muscle mass in hospitalized geriatric patients. Aging Clin Exp Res. 2024;36(1):25.<pub-id pub-id-type="pmid">38321234</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>YS</given-names></name><name><surname>Kao</surname><given-names>TW</given-names></name><name><surname>Chang</surname><given-names>YW</given-names></name><name><surname>Fang</surname><given-names>WH</given-names></name><name><surname>Wang</surname><given-names>CC</given-names></name><name><surname>Wu</surname><given-names>LW</given-names></name><etal/></person-group><article-title>Calf circumference as a Novel Tool for risk of disability of the Elderly Population</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><issue>1</issue><fpage>16359</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-16347-9</pub-id><pub-id pub-id-type="pmid">29180622</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Sun YS, Kao TW, Chang YW, Fang WH, Wang CC, Wu LW, et al. Calf circumference as a Novel Tool for risk of disability of the Elderly Population. Sci Rep. 2017;7(1):16359.<pub-id pub-id-type="pmid">29180622</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>GM</given-names></name><name><surname>Song</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Tak</surname><given-names>YJ</given-names></name><name><surname>Wang</surname><given-names>IJ</given-names></name><name><surname>Huh</surname><given-names>U</given-names></name><etal/></person-group><article-title>Diagnostic significance of calf circumference in Sarcopenia of healthy Korean adult males</article-title><source>Front Physiol</source><year>2022</year><volume>13</volume><fpage>973265</fpage><pub-id pub-id-type="doi">10.3389/fphys.2022.973265</pub-id><pub-id pub-id-type="pmid">36187765</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Kim GM, Song S, Park JH, Tak YJ, Wang IJ, Huh U, et al. Diagnostic significance of calf circumference in Sarcopenia of healthy Korean adult males. Front Physiol. 2022;13:973265.<pub-id pub-id-type="pmid">36187765</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>K</given-names></name><name><surname>Imagama</surname><given-names>S</given-names></name><name><surname>Ando</surname><given-names>K</given-names></name><name><surname>Nakashima</surname><given-names>H</given-names></name><name><surname>Machino</surname><given-names>M</given-names></name><name><surname>Morozumi</surname><given-names>M</given-names></name><etal/></person-group><article-title>Dynapenia and physical performance in community-dwelling elderly people in Japan</article-title><source>Nagoya J Med Sci</source><year>2020</year><volume>82</volume><issue>3</issue><fpage>415</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">33132426</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Kobayashi K, Imagama S, Ando K, Nakashima H, Machino M, Morozumi M, et al. Dynapenia and physical performance in community-dwelling elderly people in Japan. Nagoya J Med Sci. 2020;82(3):415&#x02013;24.<pub-id pub-id-type="pmid">33132426</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Lord</surname><given-names>SR</given-names></name><name><surname>Murray</surname><given-names>SM</given-names></name><name><surname>Chapman</surname><given-names>K</given-names></name><name><surname>Munro</surname><given-names>B</given-names></name><name><surname>Tiedemann</surname><given-names>A</given-names></name></person-group><article-title>Sit-to-stand performance depends on sensation, speed, balance, and psychological status in addition to strength in older people</article-title><source>J Gerontol Biol Sci Med Sci</source><year>2002</year><volume>57</volume><issue>8</issue><fpage>M539</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1093/gerona/57.8.M539</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Lord SR, Murray SM, Chapman K, Munro B, Tiedemann A. Sit-to-stand performance depends on sensation, speed, balance, and psychological status in addition to strength in older people. J Gerontol Biol Sci Med Sci. 2002;57(8):M539&#x02013;43.</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Anusitviwat</surname><given-names>C</given-names></name><name><surname>Vanitcharoenkul</surname><given-names>E</given-names></name><name><surname>Chotiyarnwong</surname><given-names>P</given-names></name><name><surname>Unnanuntana</surname><given-names>A</given-names></name></person-group><article-title>Dual-Frequency Bioelectrical Impedance Analysis is Accurate and Reliable to determine lean muscle Mass in the Elderly</article-title><source>J Clin Densitom</source><year>2023</year><volume>26</volume><issue>1</issue><fpage>90</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.jocd.2022.12.006</pub-id><pub-id pub-id-type="pmid">36567160</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Anusitviwat C, Vanitcharoenkul E, Chotiyarnwong P, Unnanuntana A. Dual-Frequency Bioelectrical Impedance Analysis is Accurate and Reliable to determine lean muscle Mass in the Elderly. J Clin Densitom. 2023;26(1):90&#x02013;6.<pub-id pub-id-type="pmid">36567160</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Rose Berlin Piodena-Aportadera</surname><given-names>M</given-names></name><name><surname>Lau</surname><given-names>S</given-names></name><name><surname>Chew</surname><given-names>J</given-names></name><name><surname>Lim</surname><given-names>JP</given-names></name><name><surname>Ismail</surname><given-names>NH</given-names></name><name><surname>Ding</surname><given-names>YY</given-names></name><etal/></person-group><article-title>Calf circumference measurement protocols for Sarcopenia Screening: differences in Agreement, Convergent Validity and Diagnostic Performance</article-title><source>Ann Geriatr Med Res</source><year>2022</year><volume>26</volume><issue>3</issue><fpage>215</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.4235/agmr.22.0057</pub-id><pub-id pub-id-type="pmid">36031936</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Rose Berlin Piodena-Aportadera M, Lau S, Chew J, Lim JP, Ismail NH, Ding YY, et al. Calf circumference measurement protocols for Sarcopenia Screening: differences in Agreement, Convergent Validity and Diagnostic Performance. Ann Geriatr Med Res. 2022;26(3):215&#x02013;24.<pub-id pub-id-type="pmid">36031936</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>LK</given-names></name><name><surname>Woo</surname><given-names>J</given-names></name><name><surname>Assantachai</surname><given-names>P</given-names></name><name><surname>Auyeung</surname><given-names>TW</given-names></name><name><surname>Chou</surname><given-names>MY</given-names></name><name><surname>Iijima</surname><given-names>K</given-names></name><etal/></person-group><article-title>Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia diagnosis and treatment</article-title><source>J Am Med Dir Assoc</source><year>2020</year><volume>21</volume><issue>3</issue><fpage>300</fpage><lpage>e72</lpage><pub-id pub-id-type="doi">10.1016/j.jamda.2019.12.012</pub-id><pub-id pub-id-type="pmid">32033882</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300&#x02013;e72.<pub-id pub-id-type="pmid">32033882</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Barbosa-Silva</surname><given-names>TG</given-names></name><name><surname>Menezes</surname><given-names>AM</given-names></name><name><surname>Bielemann</surname><given-names>RM</given-names></name><name><surname>Malmstrom</surname><given-names>TK</given-names></name><name><surname>Gonzalez</surname><given-names>MC</given-names></name></person-group><article-title>Enhancing SARC-F: improving Sarcopenia Screening in the clinical practice</article-title><source>J Am Med Dir Assoc</source><year>2016</year><volume>17</volume><issue>12</issue><fpage>1136</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1016/j.jamda.2016.08.004</pub-id><pub-id pub-id-type="pmid">27650212</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Barbosa-Silva TG, Menezes AM, Bielemann RM, Malmstrom TK, Gonzalez MC. Enhancing SARC-F: improving Sarcopenia Screening in the clinical practice. J Am Med Dir Assoc. 2016;17(12):1136&#x02013;41.<pub-id pub-id-type="pmid">27650212</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>J</given-names></name><name><surname>Upadhye</surname><given-names>S</given-names></name><name><surname>Worster</surname><given-names>A</given-names></name></person-group><article-title>Understanding receiver operating characteristic (ROC) curves</article-title><source>Cjem</source><year>2006</year><volume>8</volume><issue>1</issue><fpage>19</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1017/S1481803500013336</pub-id><pub-id pub-id-type="pmid">17175625</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Fan J, Upadhye S, Worster A. Understanding receiver operating characteristic (ROC) curves. Cjem. 2006;8(1):19&#x02013;20.<pub-id pub-id-type="pmid">17175625</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Nahm</surname><given-names>FS</given-names></name></person-group><article-title>Receiver operating characteristic curve: overview and practical use for clinicians</article-title><source>Korean J Anesthesiol</source><year>2022</year><volume>75</volume><issue>1</issue><fpage>25</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.4097/kja.21209</pub-id><pub-id pub-id-type="pmid">35124947</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Nahm FS. Receiver operating characteristic curve: overview and practical use for clinicians. Korean J Anesthesiol. 2022;75(1):25&#x02013;36.<pub-id pub-id-type="pmid">35124947</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>DeLong</surname><given-names>ER</given-names></name><name><surname>DeLong</surname><given-names>DM</given-names></name><name><surname>Clarke-Pearson</surname><given-names>DL</given-names></name></person-group><article-title>Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach</article-title><source>Biometrics</source><year>1988</year><volume>44</volume><issue>3</issue><fpage>837</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.2307/2531595</pub-id><pub-id pub-id-type="pmid">3203132</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837&#x02013;45.<pub-id pub-id-type="pmid">3203132</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Trajman</surname><given-names>A</given-names></name><name><surname>Luiz</surname><given-names>RR</given-names></name></person-group><article-title>McNemar chi2 test revisited: comparing sensitivity and specificity of diagnostic examinations</article-title><source>Scand J Clin Lab Invest</source><year>2008</year><volume>68</volume><issue>1</issue><fpage>77</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1080/00365510701666031</pub-id><pub-id pub-id-type="pmid">18224558</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Trajman A, Luiz RR. McNemar chi2 test revisited: comparing sensitivity and specificity of diagnostic examinations. Scand J Clin Lab Invest. 2008;68(1):77&#x02013;80.<pub-id pub-id-type="pmid">18224558</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Gandham</surname><given-names>A</given-names></name><name><surname>Gregori</surname><given-names>G</given-names></name><name><surname>Johansson</surname><given-names>L</given-names></name><name><surname>Johansson</surname><given-names>H</given-names></name><name><surname>Harvey</surname><given-names>NC</given-names></name><name><surname>Vandenput</surname><given-names>L</given-names></name><etal/></person-group><article-title>Sarcopenia definitions and their association with fracture risk in older Swedish women</article-title><source>J Bone Min Res</source><year>2024</year><volume>39</volume><issue>4</issue><fpage>453</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1093/jbmr/zjae026</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Gandham A, Gregori G, Johansson L, Johansson H, Harvey NC, Vandenput L, et al. Sarcopenia definitions and their association with fracture risk in older Swedish women. J Bone Min Res. 2024;39(4):453&#x02013;61.</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>S</given-names></name><name><surname>Larsson</surname><given-names>SC</given-names></name></person-group><article-title>Epidemiology of Sarcopenia: prevalence, risk factors, and consequences</article-title><source>Metabolism</source><year>2023</year><volume>144</volume><fpage>155533</fpage><pub-id pub-id-type="doi">10.1016/j.metabol.2023.155533</pub-id><pub-id pub-id-type="pmid">36907247</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Yuan S, Larsson SC. Epidemiology of Sarcopenia: prevalence, risk factors, and consequences. Metabolism. 2023;144:155533.<pub-id pub-id-type="pmid">36907247</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Ida</surname><given-names>S</given-names></name><name><surname>Kaneko</surname><given-names>R</given-names></name><name><surname>Murata</surname><given-names>K</given-names></name></person-group><article-title>SARC-F for Screening of Sarcopenia among older adults: a Meta-analysis of Screening Test Accuracy</article-title><source>J Am Med Dir Assoc</source><year>2018</year><volume>19</volume><issue>8</issue><fpage>685</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.jamda.2018.04.001</pub-id><pub-id pub-id-type="pmid">29778639</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Ida S, Kaneko R, Murata K. SARC-F for Screening of Sarcopenia among older adults: a Meta-analysis of Screening Test Accuracy. J Am Med Dir Assoc. 2018;19(8):685&#x02013;9.<pub-id pub-id-type="pmid">29778639</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Kera</surname><given-names>T</given-names></name><name><surname>Kawai</surname><given-names>H</given-names></name><name><surname>Hirano</surname><given-names>H</given-names></name><name><surname>Kojima</surname><given-names>M</given-names></name><name><surname>Watanabe</surname><given-names>Y</given-names></name><name><surname>Motokawa</surname><given-names>K</given-names></name><etal/></person-group><article-title>Limitations of SARC-F in the diagnosis of Sarcopenia in community-dwelling older adults</article-title><source>Arch Gerontol Geriatr</source><year>2020</year><volume>87</volume><fpage>103959</fpage><pub-id pub-id-type="doi">10.1016/j.archger.2019.103959</pub-id><pub-id pub-id-type="pmid">31945638</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Kera T, Kawai H, Hirano H, Kojima M, Watanabe Y, Motokawa K, et al. Limitations of SARC-F in the diagnosis of Sarcopenia in community-dwelling older adults. Arch Gerontol Geriatr. 2020;87:103959.<pub-id pub-id-type="pmid">31945638</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>AC</given-names></name><name><surname>Liu</surname><given-names>LK</given-names></name><name><surname>Lee</surname><given-names>WJ</given-names></name><name><surname>Peng</surname><given-names>LN</given-names></name><name><surname>Chen</surname><given-names>LK</given-names></name></person-group><article-title>Calf circumference as a screening instrument for appendicular muscle Mass Measurement</article-title><source>J Am Med Dir Assoc</source><year>2018</year><volume>19</volume><issue>2</issue><fpage>182</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1016/j.jamda.2017.11.016</pub-id><pub-id pub-id-type="pmid">29306606</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Hwang AC, Liu LK, Lee WJ, Peng LN, Chen LK. Calf circumference as a screening instrument for appendicular muscle Mass Measurement. J Am Med Dir Assoc. 2018;19(2):182&#x02013;4.<pub-id pub-id-type="pmid">29306606</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Vanitcharoenkul</surname><given-names>E</given-names></name><name><surname>Unnanuntana</surname><given-names>A</given-names></name><name><surname>Chotiyarnwong</surname><given-names>P</given-names></name><name><surname>Laohaprasitiporn</surname><given-names>P</given-names></name><name><surname>Adulkasem</surname><given-names>N</given-names></name><name><surname>Asavamongkolkul</surname><given-names>A</given-names></name><etal/></person-group><article-title>Sarcopenia in Thai community-dwelling older adults: a national, cross-sectional, epidemiological study of prevalence and risk factors</article-title><source>BMC Public Health</source><year>2024</year><volume>24</volume><issue>1</issue><fpage>311</fpage><pub-id pub-id-type="doi">10.1186/s12889-024-17804-7</pub-id><pub-id pub-id-type="pmid">38281041</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Vanitcharoenkul E, Unnanuntana A, Chotiyarnwong P, Laohaprasitiporn P, Adulkasem N, Asavamongkolkul A, et al. Sarcopenia in Thai community-dwelling older adults: a national, cross-sectional, epidemiological study of prevalence and risk factors. BMC Public Health. 2024;24(1):311.<pub-id pub-id-type="pmid">38281041</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Asai</surname><given-names>C</given-names></name><name><surname>Akao</surname><given-names>K</given-names></name><name><surname>Adachi</surname><given-names>T</given-names></name><name><surname>Iwatsu</surname><given-names>K</given-names></name><name><surname>Fukuyama</surname><given-names>A</given-names></name><name><surname>Ikeda</surname><given-names>M</given-names></name><etal/></person-group><article-title>Maximal calf circumference reflects calf muscle mass measured using magnetic resonance imaging</article-title><source>Arch Gerontol Geriatr</source><year>2019</year><volume>83</volume><fpage>175</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.archger.2019.04.012</pub-id><pub-id pub-id-type="pmid">31071533</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Asai C, Akao K, Adachi T, Iwatsu K, Fukuyama A, Ikeda M, et al. Maximal calf circumference reflects calf muscle mass measured using magnetic resonance imaging. Arch Gerontol Geriatr. 2019;83:175&#x02013;8.<pub-id pub-id-type="pmid">31071533</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Maxim</surname><given-names>LD</given-names></name><name><surname>Niebo</surname><given-names>R</given-names></name><name><surname>Utell</surname><given-names>MJ</given-names></name></person-group><article-title>Screening tests: a review with examples</article-title><source>Inhal Toxicol</source><year>2014</year><volume>26</volume><issue>13</issue><fpage>811</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.3109/08958378.2014.955932</pub-id><pub-id pub-id-type="pmid">25264934</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Maxim LD, Niebo R, Utell MJ. Screening tests: a review with examples. Inhal Toxicol. 2014;26(13):811&#x02013;28.<pub-id pub-id-type="pmid">25264934</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>JY</given-names></name><name><surname>Yu</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>CW</given-names></name><name><surname>Bao</surname><given-names>YY</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><etal/></person-group><article-title>Validity of the modified versions of SARC-F&#x02009;+&#x02009;EBM for Sarcopenia screening and diagnosis in China: the PPLSS study</article-title><source>Asia Pac J Clin Nutr</source><year>2024</year><volume>33</volume><issue>1</issue><fpage>94</fpage><lpage>1013</lpage><pub-id pub-id-type="pmid">38494691</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Guo JY, Yu K, Li CW, Bao YY, Zhang Y, Wang F, et al. Validity of the modified versions of SARC-F&#x02009;+&#x02009;EBM for Sarcopenia screening and diagnosis in China: the PPLSS study. Asia Pac J Clin Nutr. 2024;33(1):94&#x02013;1013.<pub-id pub-id-type="pmid">38494691</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Krzymi&#x00144;ska-Siemaszko</surname><given-names>R</given-names></name><name><surname>Deskur-&#x0015a;mielecka</surname><given-names>E</given-names></name><name><surname>Kalu&#x0017a;niak-Szymanowska</surname><given-names>A</given-names></name><name><surname>Murawiak</surname><given-names>M</given-names></name><name><surname>Wieczorowska-Tobis</surname><given-names>K</given-names></name></person-group><article-title>Comparison of Diagnostic Value of the SARC-F and its four modified versions in Polish Community-Dwelling older adults</article-title><source>Clin Interv Aging</source><year>2023</year><volume>18</volume><fpage>783</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.2147/CIA.S408616</pub-id><pub-id pub-id-type="pmid">37215395</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Krzymi&#x00144;ska-Siemaszko R, Deskur-&#x0015a;mielecka E, Kalu&#x0017a;niak-Szymanowska A, Murawiak M, Wieczorowska-Tobis K. Comparison of Diagnostic Value of the SARC-F and its four modified versions in Polish Community-Dwelling older adults. Clin Interv Aging. 2023;18:783&#x02013;97.<pub-id pub-id-type="pmid">37215395</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Kawakami</surname><given-names>R</given-names></name><name><surname>Miyachi</surname><given-names>M</given-names></name><name><surname>Sawada</surname><given-names>SS</given-names></name><name><surname>Torii</surname><given-names>S</given-names></name><name><surname>Midorikawa</surname><given-names>T</given-names></name><name><surname>Tanisawa</surname><given-names>K</given-names></name><etal/></person-group><article-title>Cut-offs for calf circumference as a screening tool for low muscle mass: WASEDA&#x02019;s Health Study</article-title><source>Geriatr Gerontol Int</source><year>2020</year><volume>20</volume><issue>10</issue><fpage>943</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1111/ggi.14025</pub-id><pub-id pub-id-type="pmid">32886830</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Kawakami R, Miyachi M, Sawada SS, Torii S, Midorikawa T, Tanisawa K, et al. Cut-offs for calf circumference as a screening tool for low muscle mass: WASEDA&#x02019;s Health Study. Geriatr Gerontol Int. 2020;20(10):943&#x02013;50.<pub-id pub-id-type="pmid">32886830</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>